AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹195 Cr | ₹168 Cr | ₹171 Cr | ₹166 Cr | ₹205 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹195 Cr |
| Mar2025 | ₹168 Cr |
| Mar2024 | ₹171 Cr |
| Mar2023 | ₹166 Cr |
| Mar2022 | ₹205 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹195 Cr | 15.91 | |
| Mar2025 | ₹168 Cr | -1.90 | |
| Mar2024 | ₹171 Cr | 3.07 | |
| Mar2023 | ₹166 Cr | -18.89 | |
| Mar2022 | ₹205 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,414.6 Cr | -5.7% | -12.2% | -27.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -5.7% |
-12.2% |
-27.5% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses